| Date Filed | Type | Description |
| 10/27/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 10/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/26/2022 |
4
| Ho Peter Tai-Ching (Director) has filed a Form 4 on Aravive, Inc.|
Txns:
| Granted 97,063 options to buy
@ $0.9152, valued at
$88.8k
|
|
| 09/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/21/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/25/2017 |
4
| Ho Peter Tai-Ching (Chief Development Officer) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Sold 15,000 shares
@ $16.4394, valued at
$246.6k
Exercised 15,000 options to buy
@ $8.98, valued at
$134.7k
|
|
| 09/26/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/28/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/26/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/26/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/09/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/12/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/01/2016 |
4
| Ho Peter Tai-Ching (Chief Development Officer) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 1,362 shares
@ $6.2135, valued at
$8.5k
|
|
| 03/31/2016 |
4/A
| Ho Peter Tai-Ching (Chief Development Officer) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Bought 2,000 shares
@ $16.51, valued at
$33k
|
|
| 03/02/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |